Aurobindo Pharma strengthens on getting USFDA nod for anti-AIDS combination drug

03 Apr 2013 Evaluate

Aurobindo Pharma is currently trading at Rs. 160.05, up by 2.60 points or 1.65% from its previous closing of Rs. 157.45 on the BSE.

The scrip opened at Rs. 157.00 and has touched a high and low of Rs. 162.50 and Rs. 153.50 respectively. So far 659674 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 204.90 on 07-Jan-2013 and a 52 week low of Rs. 99.65 on 10-Aug-2012.

Last one week high and low of the scrip stood at Rs. 162.50 and Rs. 127.15 respectively. The current market cap of the company is Rs. 4641.91 crore.

The promoters holding in the company stood at 54.76% while Institutions and Non-Institutions held 30.42% and 14.82% respectively.

Aurobindo Pharma has received tentative approval from the US Food & Drug Administration (USFDA) to manufacture and market its anti-AIDS combination drug Efavirenz / Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 600mg/200mg/300mg.

Efavirenz / Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 600mg/200mg/300mg is the generic equivalent of Gilead Sciences Inc’s  Atripla Tablets 600mg/200mg/300mg  and falls under the Anti-Retroviral (ARV) segment. It is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. This ANDA was reviewed under the expedited provisions of the President’s Emergency Plan for AIDS relief (PEPFAR). 

Aurobindo now has a total of 182 ANDA approvals (156 Final approvals including 2 from Aurolife Pharma LLC and 26 Tentative approvals) from USFDA.

Aurobindo Pharma Share Price

1176.65 -40.80 (-3.35%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×